Director — Eric R. Ball, Timothy E. Baxter: The filing discloses the routine addition of two new directors to the board, which is a standard governance event and not a departure of an existing executive.

Unregistered Sales of Equity Securities. On August 7, 2026, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s Registration Statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 1,958,951 shares of Company common stock, par value $0.0001 per share. A copy…

Results of Operations and Financial Condition. On August 5, 2026, IonQ, Inc. (the “ Company ”) issued a press release announcing its financial results for the second quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information provided in this Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934,…

Results of Operations and Financial Condition. On May 6, 2026, IonQ, Inc. (the “ Company ”) issued a press release announcing its financial results for the first quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information provided in this Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as…

Director — William F. Scannell: The Board added a seat and elected William F. Scannell as a new Class II director.

Unregistered Sales of Equity Securities. On March 11, 2026, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s Registration Statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by the selling stockholder of an aggregate of 2,562,642 shares of Company common stock, par value $0.0001 per share. The prospec…

Other Events. On February 27, 2026, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 5,127,459 shares of Company common stock, par value $0.0001 per share. A copy of the legal opinion of…

Results of Operations and Financial Condition. On February 25, 2026, IonQ, Inc. (the “ Company ”) issued a press release announcing its financial results for the fourth quarter ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information provided in this Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of…

The issuance of shares of common stock of the Company, par value $0.0001 per share (each, a “ Company Share ”) in connection with the transaction was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Ac t”), and/or the private offering provision of Rule 506 of Regulation D and was not previously reported in reliance on Item 3.02(b) of Form 8-K. Skyloom Global Acquisition On January 26, 2026, the Company completed…

of this Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended (the “ Securities Act ”), or the Exchange Act, except as expressly set forth by specific reference in such filing.

Entry into a Material Definitive Agreement. Agreement and Plan of Merger On January 25, 2026, IonQ, Inc., a Delaware corporation (the “ Company ”), SkyWater Technology, Inc., a Delaware corporation (“ SkyWater ”), Iris Merger Subsidiary 1 Inc., a Delaware corporation (“ Merger Sub 1 ”), and Iris Merger Subsidiary 2 LLC, a Delaware limited liability company (“ Merger Sub 2 ” and, together with Merger Sub 1, the “ Merger Subs ”), entered into an Agreement and Plan of Merger (the “ Merger Agreem…

CFO — Mr. Kramer: Mr. Kramer departed from his role as CFO and will receive severance benefits.

Chief Revenue Officer — Rima Alameddine: Ms. Alameddine's departure as Chief Revenue Officer with a severance package and no immediate successor mentioned.

Other Events. On November 10, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by the selling stockholder of an aggregate of 2,108,993 shares of Company common stock, par value $0.0001 per share. The prospectus supplement was filed…

Results of Operations and Financial Condition. On November 5, 2025, IonQ, Inc. (the “ Company ”) issued a press release announcing its financial results for the third quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information provided in this Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of…

Other Events. On October 16, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 6,649,263 shares of Company common stock, par value $0.0001 per share. A copy of the legal opinion of…

Other Events. On October 16, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 25,275,276 shares of Company common stock, par value $0.0001 per share. A copy of the legal opinion of…

Director — Bill Scannell: Bill Scannell resigned from the Board and took on a new role as Senior Commercial Advisor.

The issuance and sale of shares of IonQ, Inc. (the “ Company ”) common stock in connection with the Transaction (as defined below) was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act ”), and/or the private offering provision of Rule 506 of Regulation D.

Director — John W. Raymond: Appointment of a new director and expected resignation of another.

The issuance and sale of shares of IonQ, Inc. (the “ Company ”) common stock in connection with the Oxford Ionics Transaction (as defined below) was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act ”), and/or the private offering provision of Rule 506 of Regulation D and/or Regulation S promulgated under the Securities Act. The issuance and sale of shares of Company common stock in connection with the Vector…

CFO and COO — Inder M. Singh: Inder M. Singh was promoted to CFO and COO, stepping down from the Board.

Director — Jim Frankola and William J. Teuber, Jr.: Two new directors were appointed to the Board of Directors.

Other Events. On August 28, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 12,377,433 shares of Company common stock, par value $0.0001 per share. A copy of the legal opinion of…

The filing details equity grants and a salary increase for executive officers.